Adenosine Injection
Product Images NDC 51662-1511

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Adenosine (NDC 51662-1511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Carton Labeling (51662 1511 1 Serialized Carton Labeling 1014560 Adenosine Hf Label Image)

Box packaging for Adenosine Injection, USP, labeled as 12 mg per 4 mL (3 mg per mL) for intravenous use. The label indicates it is a single-use prefilled syringe for rapid bolus intravenous administration. Distributed by HF Acquisition Co LLC, Mukilteo, WA, with the NDC 25021-301-68 visible on the packaging.*

FDA Label Image

Syringe (51662 1511 1 Syringe Labeling 25021 301 68 Adenosine Syr Label)

ADENOSINE 12 mg per 4 mL injection syringe labeled for intravenous use. The syringe has a yellow and white label with the brand name Adenosine prominently displayed. The label includes the concentration, 12 mg/4 mL, and the product NDC 51662-1511. The syringe is clear with a gray cap on the plunger end. The back side displays a barcode and additional manufacturing information.*

FDA Label Image

Syringe And Carton (51662 1511 1 Syringe And Box Labeling 25021 301 68 Adenosine Syr And Box Label)

A packaging label and prefilled syringe for Adenosine Injection, USP, 3 mg/mL strength, with a total of 12 mg per 4 mL. The label states it is for rapid bolus intravenous use, presented in a single-use prefilled syringe. The product is labeled by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Adverse Reactions (Adverse Reactions)

A data table listing adverse reactions categorized by system for Adenosine injection. Cardiovascular effects include facial flushing (18%) and headache (2%). Respiratory effects include shortness of breath (12%) and chest pressure (7%). Central nervous system effects include lightheadedness (2%) and dizziness. Gastrointestinal effects include nausea (3%) and metallic taste.*

FDA Label Image

How Supplied (How Supplied)

A data table listing NDC codes, descriptions, and package factors for Adenosine Injection USP (3 mg per mL). It details two presentations: 6 mg per 2 mL in a single-use prefilled plastic syringe with 10 syringes per carton, and 12 mg per 4 mL in a single-use prefilled plastic syringe with 10 syringes per carton.*

FDA Label Image

Structure (Structure)

Chemical structure of Adenosine showing its molecular arrangement including nitrogenous base and sugar moiety. The diagram depicts atoms and bonds clearly associated with the compound Adenosine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.